Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

About Us

Genomics and Population Health: United States 2003

Table of Contents

I. Population Health Research

  • Chapter 1
    National Health and Nutrition Examination Survey (NHANES) III DNA Bank: Gene Variants Important to Public Health
    NHANES III DNA Bank • Collaborative CDC-Wide Proposal • Selecting Genetic Variants Important to Public Health • Potential Value for Public Health • Two Other CDC Projects Using NHANES III DNA Samples
  • Chapter 2
    Genomics and Acute Public Health Investigations
    What is an Acute Public Health Investigation (APHI)? • Incorporating Human Genomics into APHIs • APHI Working Group

II. Building the Evidence Base

  • Chapter 3
    Asthma Genomics: Implications for Public Health
    What Causes Asthma? • Public Health Implications of Asthma Genomics Research • Pharmacogenomics and Predictive Testing • Public Health Actions—Asthma Genomics Research
  • Chapter 4
    Public Health Assessment of BRCA1 and BRCA2 Testing for Breast and Ovarian Cancer
    Breast and Ovarian Cancer: An Important Public Health Problem • Genetic Tests for Breast and Ovarian Cancer Susceptibility • A Public Health Perspective • The Role of Family History in BRCA1 and BRCA2 Testing • The Role of Genetic Counseling in BRCA1 and BRCA2 Testing • Surveillance and Risk-Reducing Strategies for Breast and Ovarian Cancer
    • Evaluation of BRCA1 and BRCA2 Testing in Practice • Effectiveness of BRCA1 and BRCA2 Testing for Prevention
  • Chapter 5
    Newborn Screening for MCAD Deficiency
    What is MCADD? • Why Test Newborns for MCADD? • Tandem Mass Spectrometry Screening Test • Adding MCADD Screening to Existing Newborn Screening Programs • Is Universal Screening for MCADD Justified? • Cost-Effectiveness of Newborn MCADD Screening
    • Challenges for Implementing MCADD Screening
  • Chapter 6
    The Family History Public Health Initiative
    Family History is Valuable for Prevention • Disease Risk Due to Gene-Environment Interactions • Role of Genetic Testing • Family History and the Family Tree • The CDC Family History Initiative • Selecting Diseases to Include in a Family History Tool • Prototype Family History Tool • Data Collection • Classification • Intervention • Evaluation Studies
  • Chapter 7
    Genetic Testing and the Prevention of Coronary Heart Disease: A Case Study
    Will a Genomic Profile Help Prevent Coronary Heart Disease (CHD)? • Is Genomic Profiling for CHD Ready for Prime Time? • Medical Family History as Genomic Profiling • Family History is Still the Best Genomic Tool • Guidelines for CHD Prevention
  • Chapter 8
    Genomics and Public Health: Ethical, Legal, and Social Issues
    Ethical, Legal, and Social Issues (ELSI) • Public Health Ethical Legal, and Social Issues (PHELSI) • Is PHELSI Different from ELSI? • Public Health Ethics • Ethical Issues in Public Health Genomics • Legal Issues in Public Health Genomics • Social Issues in Public Health Genomics • Engagement and Education to Address PHELSI • A Genetic Agenda for Public Health

III. Genomics in Practice

  • Chapter 9
    Carrier Testing for Cystic Fibrosis: Transition from Research to Clinical Practice
    About Cystic Fibrosis • CFTR: The CF Gene • Cystic Fibrosis Carrier Testing • History of CF Testing in the United States • CF Testing in the United States: Transition from Research to Clinical Practice • Evaluation of Prenatal CF Screening • 2003: Learning from Implementation and Practice • Public Health Importance of Lessons Learned
  • Chapter 10
    Ensuring the Quality of Genetic Testing in the United States
    Why is the Quality of Genetic Testing Important to Public Health? • Genetic Testing Issues • Who Considers These Issues in the United States? • What Oversight Currently Exists for Genetic Testing? • “Home Brew” Genetic Tests and the FDA • How Do States Regulate Genetic Testing? • What Private Sector Organizations Are Concerned with Genetic Testing? • What is Needed to Ensure the Safety of Genetic Testing? • How is CDC Addressing These Needs?
  • Chapter 11
    Hemochromatosis: Information and Resources for Health Care Providers
    What is Hemochromatosis? • Why is Hemochromatosis a Public Health Problem? • Is Population Screening Recommended for Hemochromatosis? • CDC’S Online Training on Hemochromatosis for Health Care Providers
  • Chapter 12
    Genomics Training for Public Health Practice: The Michigan Experience
    Why Does the Public Health Workforce Need Genomics Training? • What Has Been Done to Develop Genomics Training? • Simple Training Strategies and Available Courses • Strategy 1: Building a Foundation—Know Your Audience • Strategy 2: Raising Awareness and Stimulating Interest • Strategy 3: Increasing Knowledge • Strategy 4: Strengthening Skills
    • Strategy 5: Using Evaluation to Improve Training • Lessons Learned
  • Chapter 13
    Genomics Tools for Public Health
    What are Genomic Tools? • Genomic Tools in Practice and the Genomics Toolkit • Genomic Tools We Need, But Don’t Currently Have • How Will New Tools Be Developed? • Thinking Genomically—the Vision for the Future
  • Chapter 14
    State Capacity Grants for Integrating Genomics into Chronic Disease Prevention Programs
    Michigan, Minnesota, Oregon and Utah Genomics and Chronic Disease Prevention Programs • Michigan • Minnesota • Oregon • Utah • Next Steps
  • Chapter 15
    Internet Resources for Genomics and Disease Prevention
    CDC Office of Genomics and Disease Prevention(OGDP) • Human Genome Project
    • Genomic Research • Genetic Testing • Family History • Genes and Diseases • Cancer • Birth Defects • Newborn Screening • Public Health Ethical, Legal, and Social Issues (PHELSI) • Policy • Public Health Resources • Educational Resources

Top of Page


Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd.
    Atlanta, GA 30333 USA
    800-CDC-INFO (800-232-4636)
  • Additional information for Public Health Genomics is available on our contact page. The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #